Daily news and information for physicians in a range of specialties and practice settings.
In an industry-wide survey, 72.2% of healthcare providers report satisfaction with their own success.
The findings of a recent study emphasize the importance of learning the risk factors that contribute to pediatric suicide. 
PDUFA target action date set for November 15, 2020 for the new combination olanzapine/samidorphan treatment.
The remote patient monitoring platform delivers data directly to the physician and reduces hospitalizations and emergency department trips. 
The FDA will rule on the type 2 inflammation-targeting biologic for another indication this May.
The SoMeDocs founder shares thoughts on doctors developing an online brand, the burden of being an uncredited expert on social media, and the benefit of committing to the platforms.
Compared with other antihypertensive medications, amlodipine was found to reduce risk of gout in older patients.
Psilocybin, which is commonly found in psychedelic mushrooms, is linked with enduring antianxiety and antidepressant effects.
An oral tablet combining empagliflozin, linagliptin, metformin hydrochloride will soon be available on US markets.
New data from the Annual Meeting of the Society of Thoracic Surgeons reveals a three-day stay is not associated with increased risk of worse outcomes or readmission. 
Copyright© MD Magazine 2006-2020 Intellisphere, LLC. All Rights Reserved.